The finding that IL-36R deficiency enhances IL-1Ra expression and promotes effective epithelial wound closure in DM corneas suggests the therapeutic potential of IL-1Ra and IL-1ra. This evidence concerns the gene IL1RL2 and diabetes mellitus.